Diclomezin
CAS: 62865-36-5
Ref. 3D-MCA86536
| 5mg | Nachfragen | ||
| 10mg | Nachfragen | ||
| 25mg | Nachfragen | ||
| 50mg | Nachfragen | ||
| 100mg | Nachfragen |
Produktinformation
- 3(2H)-Pyridazinone, 6-(3,5-dichloro-4-methylphenyl)-
- 6-(3,5-dichloro-4-methylphenyl)-3(2H)-pyridazinone
- 6-(3,5-dichloro-4-methylphenyl)pyridazin-3(2H)-one
- Monguard
Diclomezin is a medicinal analog that has been shown to inhibit the activity of tumor kinases in human cancer cells. It acts as an inhibitor of protein kinases, leading to apoptosis or programmed cell death in cancer cells. Diclomezin has been found to be effective against various types of cancers, including lung and breast cancers. This anticancer drug has also been shown to have a favorable safety profile, with no significant side effects reported in clinical trials. Diclomezin is excreted through urine and has been extensively studied as a potential therapeutic agent for cancer treatment. This inhibitor may have promising applications in the development of novel therapies for Chinese patients suffering from cancer.
Chemische Eigenschaften
Technische Anfrage zu: 3D-MCA86536 Diclomezin
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
